Pfizer and BioNTech seek EU clearance for COVID-19 vaccine - Business Insider
2 min read
fairly difficult
If EU regulators do not decide on Pfizer's COVID-19 vaccine until December 29, which is possible, rollout this year would be very difficult.
Pfizer and partner BioNTech said Tuesday they have asked the EU to approve their coronavirus vaccine.

Regulator the European Medicines Agency said in a press release that it might not decide whether the COVID-19 vaccine is safe and effective enough until December 29.

Approval on December 29 would make an EU vaccine rollout this year almost impossible.

The drugmaker's application to the EMA follows authorization applications in the US on November 20 and the UK on November 23.

Visit Business Insider's homepage for more stories.

Pfizer and its German partner BioNTech said Tuesday they have asked the European Union to approve their COVID-19 vaccine, but that distribution is unlikely to start until…
Kate Duffy
Read full article